Ambit Health Ventures — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Osteoboost is an FDA-cleared, drug-free prescription device that uses precision vibration therapy to slow bone density and strength loss in postmenopausal women with osteopenia.
Digital HealthFemTechMedical Devices
Dan Burnett(Co-Founder)inMichael Jaasma(Chief Scientific Officer and Co-Founder)inShane Mangrum(Co-Founder)inLaura Yecies(Chief Executive Officer & President)inPamela M. Peeke(Chief Medical Officer)in
Co-investorsEsplanade VenturesBand of AngelsGolden SeedsGood Growth CapitalHealthtech CapitalNew York Angels+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







